2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC25
Submitter : Ms. Colleen Meegan Date & Time: 09/01/2005 04:09:34
Organization : Ms. Colleen Meegan
Category : Individual Consumer
Issue Areas/Comments
1
A. Should FDA initiate a rulemaking to codify its interpretation of section 503(b) of the action regarding when an active ingredient can be simultaneously marketed in both prescription drug product and an OTC drug product?
yes
1.
A. Should FDA initiate a rulemaking to codify its interpretation of section 503(b) of the act regarding when an active ingredient can be simultaneously market in both a prescription drug product and an OTC drug product?
yes
B. Is there significant confusion regarding FDA's interpretation of section 503(b) of the act?
not sure
C. If so, would a rulemaking on this issue help dispet that confusion?
yes
2
A. If FDA limited sale of an OTC product to a particular subpopulation, e.g., by making the product available to the subpopulation by prescription only, would FDA be able to enforce such a limitation as a matter of law?
yes--put the drug behind the counter where the pharmacist can photo ID the customer
B. If it could, would it be able to do so as practical matter and, if so, how?
as above
3
A. Assuming it is legal to market the same active ingredient in both a prescription and OTC product, may the different products be legally sold in the same package?
yes
B. If the two products may be lawfully sold in a single package, under what circumstances would it be inappropriate to do so?
not sure
GENERAL
GENERAL
I have commented only on this law thus far--but I would like to make a comment on the drug in question---is it safe? I support women's right to choose birth control, but not at the expense of doing her harm. Is Plan B safe? If so, this is a good choice for the FDA across the board.